Buy PharmaCyte Biotech

In: Tips

20 Jan 2015

Hi Everybody,

Our alert for Tuesday is:
PharmaCyte Biotech, Inc..
Ticker symbol: PMCB
Last price: $0.1675

PMCB is a clinical stage biotechnology company developing targeted treatments for cancer and diabetes using its signature live cell encapsulation technology Cell-in-a-Box®.

PMCB’s Cell-in-a-Box® is a way to enclose living cells in protective “cocoons” about the size of the head of a pin. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This “targeted chemotherapy” has proven remarkably effective in past clinical trials.

Reasons why should you be buying this stock:

1. This technology shows great promise. As a matter of fact, in the first round of testing patients received two courses of ifosfamide at one-third the regular dose plus a urological protectant after transplantation of 300 capsules. Median survival after diagnosis rose to 40 weeks, compared with historical control of 28 weeks with gemcitabine, and 1-year survival increased to 36%, compared with 18% for gemcitabine.

2. The European Medicines Agency (The European version of the FDA) has fast-tracked this treatment in order to cut the time it takes to get to market. That is obviously a great thing for patients and investors.

3. PMCB’s cell-in-a-box technology was named a Near Term Approach in the the Journal of the National Cancer Institute. The JNCI was established in 1940 and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. Coverage in the Journal of the National Cancer Institute brings the kind of credibility that investors like to see when making long term bets on microcap companies.

This is why we’re excited to bring you a company in phase 2b of clinical trials for treating the terrible disease.

So while their current clinical trials are centered around the ability to treat pancreatic cancer, there is potential for this technology to treat several forms of cancer.

Biotechs can yield some of the largest returns out of any other industry in the microcap space, so when we find one with a story like this, we get pretty excited.

Make sure you’re ready to book your profits with PMCB!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Comment Form

*



Categories